English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Sam Jackson | Apr 25, 2023

Teriflunomide study shows promise in delaying first symptoms of MS using medication as an 'early intervention'

Sam Jackson | Apr 25, 2023

New drug shows promise in preventing migraines for patients unresponsive to other treatments: 'These results are exciting'

Patient Daily Report | Apr 24, 2023

Study on mice 'presents a potential pathway' for reversing or preventing graying of human hair

Patient Daily | Apr 24, 2023

H1.co Named 2023 Website of the Year by the Health and IT Marketing Community

Patient Daily | Apr 24, 2023

The University of Maryland Medical Center Chooses SOPHiA GENETICS Technology

Patient Daily | Apr 24, 2023

Alliance between Telstar and Picarro

Patient Daily | Apr 24, 2023

Telstar DiSQ, Digital Smart Qualification

Patient Daily | Apr 24, 2023

Weave Adds 3 New Integrated Experiences for Veterinary Clinics

Trending

Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors

+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’

+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’

+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’

  • « First
  • «
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily